Nutrition services during prostate cancer androgen deprivation therapy

被引:2
|
作者
Baguley, Brenton [1 ,4 ]
Smith-Gillis, Caity [2 ]
Porter, Judi [1 ]
Kiss, Nicole [1 ]
Ugalde, Anna [3 ]
机构
[1] Deakin Univ, Inst Phys Act & Nutr, Geelong, Vic, Australia
[2] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Vic, Australia
[3] Deakin Univ, Inst Hlth Transformat, Burwood, Vic, Australia
[4] Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic 3125, Australia
关键词
prostate; quality of life; supportive care; survivorship; QUALITY-OF-LIFE; MEN; SOCIETY; HEALTH; RISK; DIET; GUIDELINES; DIAGNOSIS; MORTALITY; SURVIVORS;
D O I
10.1136/spcare-2023-004304
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ObjectiveDietary interventions are effective strategies to mitigate multiple side effects from androgen deprivation therapy (ADT) in prostate cancer, however the perception of, and access to, nutrition services is relatively unknown. MethodsA qualitative study using semistructured, audio recorded interviews was conducted in men with prostate cancer treated with ADT for & GE;3 months. Interviews explored (1) side effects of ADT and drivers for dietary change, (2) accessibility, barriers, facilitators and use of nutrition services and (3) the preferences for nutrition service delivery. Data were coded using interpretative descriptive techniques of textual interview data, and systematically summarised to generate thematical patterns, using NVivo software. ResultsInterviews were completed of 20 men with prostate cancer treated with ADT (25.5 & PLUSMN;20.1 months). Thematic analysis revealed four overarching themes-(1) the changes from ADT: men revealed that weight gain, loss of muscle and strength from ADT were daily struggles that negatively impact body image and components of masculinity reduced; (2) strategies to take control: several dietary changes were trialled and restrictive in foods and nutrients. Barriers to accessing nutrition specialists were the cost for the service and absence of a clear referral pathway; (3) importance of nutrition knowledge: demand for specialised nutrition services with knowledge in addressing side effects from ADT; (4) diverse patients need diverse nutrition support: that includes peer or partner support, and technology supported nutrition content. ConclusionEvidence-based nutrition services are an unmet need for men treated with ADT. Future work is required to develop services that can be readily available and accessible to improve prostate cancer survivorship care.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Cardiovascular risk during androgen deprivation therapy for prostate cancer
    Jones, Thomas Hugh
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [12] Interest in services among prostate cancer patients receiving androgen deprivation therapy
    Shapiro, PJ
    Coyne, JC
    Kruus, LK
    Palmer, SC
    Vaughn, DJ
    Malkowicz, SB
    PSYCHO-ONCOLOGY, 2004, 13 (08) : 512 - 525
  • [13] Insulin resistance during androgen deprivation therapy in men with prostate cancer
    Basaria, Shehzad
    Taplin, Mary-Ellen
    McDonnell, Marie
    Simonson, Donald C.
    Lin, Alexander P.
    Dufour, Alyssa B.
    Habtemariam, Daniel
    Nguyen, Paul L.
    Ravi, Praful
    Kibel, Adam S.
    Sweeney, Christopher J.
    D'Amico, Anthony V.
    Roberts, Daniel A.
    Xu, Wenxin
    Wei, Xiao X.
    Sunkara, Rajitha
    Choudhury, Atish D.
    Mantia, Charlene
    Beltran, Himisha
    Pomerantz, Mark
    Berchuck, Jacob E.
    Martin, Neil E.
    Leeman, Jonathan E.
    Mouw, Kent W.
    Kilbridge, Kerry E.
    Bearup, Richelle
    Kackley, Hannah
    Kafel, Hussein
    Huang, Grace
    Reid, Kieran F.
    Storer, Thomas
    Braga-Basaria, Milena
    Travison, Thomas G.
    CANCER, 2024, 130 (21) : 3671 - 3685
  • [14] Metabolic changes in patients with prostate cancer during androgen deprivation therapy
    Mitsuzuka, Koji
    Arai, Yoichi
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (01) : 45 - 53
  • [15] Changes in body composition during androgen deprivation therapy for prostate cancer
    Smith, MR
    Finkelstein, JS
    McGovern, FJ
    Zietman, AL
    Fallon, MA
    Schoenfeld, DA
    Kantoff, PW
    JOURNAL OF UROLOGY, 2002, 168 (01): : 378 - 379
  • [16] Sleep and daily functioning during androgen deprivation therapy for prostate cancer
    Hanisch, L. J.
    Gooneratne, N. S.
    Soin, K.
    Gehrman, P. R.
    Vaughn, D. J.
    Coyne, J. C.
    EUROPEAN JOURNAL OF CANCER CARE, 2011, 20 (04) : 549 - 554
  • [17] Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
    Keating, Nancy L.
    O'Malley, A. James
    Smith, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4448 - 4456
  • [18] miRNAs and androgen deprivation therapy for prostate cancer
    Konoshenko, Maria Yu
    Bryzgunova, Olga E.
    Laktionov, Pavel P.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [19] Changes in body composition during androgen deprivation therapy for prostate cancer
    Smith, MR
    Finkelstein, JS
    McGovern, FJ
    Zietman, AL
    Fallon, MA
    Schoenfeld, DA
    Kantoff, PW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02): : 599 - 603
  • [20] Prostate cancer, insulin, and androgen deprivation therapy
    Stattin, P
    Kaaks, R
    BRITISH JOURNAL OF CANCER, 2003, 89 (09) : 1814 - 1815